Mentzer Index

Why use it

Provides a rapid, cost-free screening calculation from routine CBC to guide further workup. Useful in resource-limited settings or when hemoglobin electrophoresis is not immediately available. Can help prioritize whether iron studies or hemoglobin analysis should be ordered first in a patient with microcytic anemia.

About

The Mentzer Index is a simple screening tool derived from the complete blood count (CBC) to help differentiate between two common causes of microcytic anemia: beta-thalassemia trait (minor) and iron deficiency anemia. It is calculated by dividing the mean corpuscular volume (MCV) by the red blood cell (RBC) count. The index exploits the fact that in thalassemia trait, the RBC count is typically elevated or normal relative to the degree of microcytosis ("many small red cells"), whereas in iron deficiency, the RBC count is usually reduced ("few small red cells"). Despite its simplicity, the Mentzer Index has limitations and should be interpreted alongside other clinical and laboratory data.

When to use

• Microcytic anemia (MCV < 80 fL) on CBC with unclear etiology
• Distinguishing iron deficiency anemia from thalassemia trait in primary care
• Screening in geographic areas with high thalassemia prevalence (Mediterranean, Middle East, Southeast Asia, Africa)
• Preconception or prenatal screening when thalassemia carrier status is uncertain
• Pediatric anemia evaluation before proceeding to hemoglobin electrophoresis

Formula

Pearls & pitfalls

• The Mentzer Index has a sensitivity of ~70% and specificity of ~80% for differentiating thalassemia trait from iron deficiency — it is a SCREENING tool, not a diagnostic test.
• Both thalassemia trait and iron deficiency can coexist — a patient with thalassemia can also be iron deficient.
• In thalassemia trait, the RBC count is characteristically elevated (often > 5.0 × 10⁶/µL) despite low MCV — the hallmark is many small cells.
• In iron deficiency, the RBC count is often low or low-normal, with a high RDW (> 14%) — few small, irregular cells.
• The England and Fraser Index (MCV − RBC − 5×Hgb − 3.4) is an alternative discriminant formula with similar performance.
• Hemoglobin electrophoresis with HbA2 quantification is the gold standard for diagnosing beta-thalassemia trait.
• Iron deficiency can lower HbA2 into the normal range even in a true thalassemia carrier, causing false-negative hemoglobin electrophoresis.
• Alpha-thalassemia cannot be diagnosed by hemoglobin electrophoresis in adults — requires DNA testing.

Next steps

Mentzer Index < 13: Suggestive of beta-thalassemia trait — order hemoglobin electrophoresis (elevated HbA2 ≥ 3.5% confirms beta-thalassemia minor). Serum ferritin and iron studies also useful to exclude concurrent iron deficiency. Mentzer Index > 13: Suggestive of iron deficiency anemia — order serum ferritin, serum iron, TIBC, reticulocyte count. Trial of iron replacement is both diagnostic and therapeutic. Mentzer Index = 13: Indeterminate — clinical context and additional testing required.

Evidence

Mentzer WC (Lancet 1973) derived the index from 121 subjects. Multiple validation studies reported sensitivity 57–90% and specificity 61–90% depending on the population. Meta-analysis by Demir et al. (J Pediatr Hematol Oncol 2002) confirmed moderate discriminative ability. Several alternative indices (England-Fraser, Shine-Lal, Green-King) have been proposed with similar or marginally better performance.

References

1. Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882. — link
2. Demir A et al. The use of the RBC indices in differentiating microcytic-hypochromic anemias. J Pediatr Hematol Oncol. 2002;24(5):388-390. — link
3. Vehapoglu A et al. Hematological indices for differential diagnosis of beta thalassemia trait and iron deficiency anemia. Anemia. 2014;2014:576738. — link